Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology
Sponsor: Eisai Limited
Summary
The primary purpose of this study is to identify participants with or without symptoms of Alzheimer's Disease (AD) that are at high risk for brain amyloid pathology using blood-based biomarkers.
Official title: A Community-Based Screening Program to Identify, Using Blood-Based Biomarkers, Individuals With or Without Alzheimer's Disease Symptoms Who Are at High Risk for Brain Amyloid Pathology
Key Details
Gender
All
Age Range
50 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2023-09-12
Completion Date
2028-03-31
Last Updated
2026-03-05
Healthy Volunteers
Yes
Conditions
Interventions
No Intervention
No treatment intervention will be administered.
Locations (3)
Eisai Site #3
Clermont, Florida, United States
Eisai Site #1
Lady Lake, Florida, United States
Eisai Site #2
District Heights, Maryland, United States